| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.7 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.064 | 0.7 |